Status:
COMPLETED
A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)
Lead Sponsor:
Virginia Center for Reproductive Medicine
Conditions:
Infertility
Eligibility:
FEMALE
21-42 years
Brief Summary
This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).
Eligibility Criteria
Inclusion
- women between 21-42 undergoing IVF
Exclusion
- women \> 45,
- women with one ovary,
- donor egg,
- surrogacy,
- FET cycles,
- uterine problems,
- large fibroids
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT01139593
Start Date
June 1 2010
End Date
December 1 2015
Last Update
December 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Center for Reproductive Medicine
Reston, Virginia, United States, 20190